Director/PDMR Shareholding

Released : 22 Jun 2017 08:36

RNS Number : 8577I
Dechra Pharmaceuticals PLC
22 June 2017
 

                                                              

 

 

 

22 June 2017

 

Dechra Pharmaceuticals PLC

Notification of Transactions by Persons Discharging Managerial Responsibilities

 

Dechra Pharmaceuticals PLC has been notified that on 21 June 2017 Ian Page, Director, sold 134,500 ordinary shares in the Company at a price of £19.27 each. 

 

Following this disposal Ian Page's beneficial interest in the Company is 676,808 shares (0.726% of the current issued share capital).

 

The Notification of Dealing Forms set out below are provided in accordance with Article 19.3 of MAR.

 

Notification of Dealing Form

 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")

a)

Name

Ian Page

 

2.

Reason for the notification

a)

Position/status

Director

 

b)

Initial notification/

amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Dechra Pharmaceuticals PLC

b)

LEI code

213800J4UVB5OWG8VX82

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification code

Ordinary Shares of 1 pence each

 

 

ISIN: GB0009633180

b)

Nature of the transaction

Sale of Shares

c)

Price(s) and volumes(s)

Price(s)

£19.27

Volume(s)

134,500

d)

Aggregated information

-  Aggregate volume

-   Price

-   Total

15,000 at 1942p

7,500 at 1934.49p

13,000 at 1935p

7,500 at 1935.42p

7,000 at 1931.32p

3,500 at 1930.6p

27,500 at 1927.5p

14,000 at 1925p

5,000 at 1925p

12,500 at 1926.42p

20,000 at 1910p

2,000 at 1910.41p

Total

134,500

1927.64p

e)

Date of the transaction

21 June 2017

 

 

f)

Place of the transaction

London Stock Exchange

 

 

 

For further information, please contact:

 

Telephone number: 01606 814730

 

 

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business.  Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

 

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHOKBDNOBKKPAB